Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Tubulopathy: the clinical and genetic approach in diagnosis

  • Jinwoon Joung (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Heeyeon Cho (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2023.01.31
  • Accepted : 2023.03.13
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Remarkable advances in genetic diagnosis expanded our knowledge about inherited tubulopathies and other genetic kidney diseases. This review suggests a simple categorization of inherited tubular disease, clarifies the concept of autosomal dominant tubulointerstitial kidney disease (ADTKD), and introduces novel therapies developed for tubulopathies. Facing patients with suspicious tubular disorders, clinicians should first evaluate the status of volume and acid-base. This step helps the clinicians to localize the affected segment and to confirm genetic diagnosis. ADTKD is a recently characterized disease entity involving tubules. The known causative genes are UMOD, MUC1, REN, and HNF1β. Still, only half of ADTKD patients show mutations for these four identified genes. Whole exome sequencing is a suitable diagnostic tool for tubulopathies, especially for ADTKD. Genetic approaches to treat tubulopathies have progressed recently. Despite the practical obstacles, novel therapies targeting inherited tubulopathies are currently in development.

Keywords

References

  1. Downie ML, Lopez Garcia SC, Kleta R, Bockenhauer D. Inherited tubulopathies of the kidney: insights from genetics. Clin J Am Soc Nephrol 2021;16:620-30. https://doi.org/10.2215/CJN.14481119
  2. Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what's new, what's controversial? J Am Soc Nephrol 2018;29:727-39. https://doi.org/10.1681/ASN.2017060600
  3. Kermond R, Mallett A, McCarthy H. A clinical approach to tubulopathies in children and young adults. Pediatr Nephrol 2023;38:651-62. https://doi.org/10.1007/s00467-022-05606-1
  4. Foreman JW. Fanconi syndrome. Pediatr Clin North Am 2019;66:159-67. https://doi.org/10.1016/j.pcl.2018.09.002
  5. Walsh SB, Unwin RJ. Renal tubular disorders. Clin Med (Lond) 2012;12:476-9. https://doi.org/10.7861/clinmedicine.12-5-476
  6. Raina R, Krishnappa V, Das A, Amin H, Radhakrishnan Y, Nair NR, et al. Overview of monogenic or mendelian forms of hypertension. Front Pediatr 2019;7:263.
  7. Alexander RT, Cordat E, Chambrey R, Dimke H, Eladari D. Acidosis and urinary calcium excretion: insights from genetic disorders. J Am Soc Nephrol 2016;27:3511-20. https://doi.org/10.1681/ASN.2016030305
  8. Alexander RT, Bitzan M. Renal tubular acidosis. Pediatr Clin North Am 2019;66:135-57. https://doi.org/10.1016/j.pcl.2018.08.011
  9. Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D. Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrol Dial Transplant 2015;30:1456-60. https://doi.org/10.1093/ndt/gfu377
  10. Bokenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol 2016;31:2201-12. https://doi.org/10.1007/s00467-016-3343-3
  11. De Matteis MA, Staiano L, Emma F, Devuyst O. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol 2017;13:455-70. https://doi.org/10.1038/nrneph.2017.83
  12. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 2015;10:1257-72. https://doi.org/10.2215/CJN.09750913
  13. Besouw MT, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: questions of class. Pediatr Nephrol 2020;35:1815-24. https://doi.org/10.1007/s00467-019-04371-y
  14. Walsh PR, Tse Y, Ashton E, Iancu D, Jenkins L, Bienias M, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes. Clin Kidney J 2018;11:302-9. https://doi.org/10.1093/ckj/sfx118
  15. Claverie-Martin F. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin Kidney J 2015;8:656-64. https://doi.org/10.1093/ckj/sfv081
  16. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11:576-88. https://doi.org/10.1038/nrneph.2015.89
  17. Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management: a KDIGO consensus report. Kidney Int 2015;88:676-83. https://doi.org/10.1038/ki.2015.28
  18. Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 2019;5:60.
  19. Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 2019;380:142-51. https://doi.org/10.1056/NEJMoa1806891
  20. Bleyer AJ, Wolf MT, Kidd KO, Zivna M, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β. Pediatr Nephrol 2022;37:933-46. https://doi.org/10.1007/s00467-021-05118-4
  21. Sinha R, Pradhan S, Banerjee S, Jahan A, Akhtar S, Pahari A, et al. Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study. Pediatr Nephrol 2022;37:1811-36. https://doi.org/10.1007/s00467-021-05388-y
  22. Ashton EJ, Legrand A, Benoit V, Roncelin I, Venisse A, Zennaro MC, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int 2018;93:961-7. https://doi.org/10.1016/j.kint.2017.10.016
  23. Hildebrandt F. Genetic kidney diseases. Lancet 2010;375:1287-95. https://doi.org/10.1016/S0140-6736(10)60236-X
  24. Rubin JD, Barry MA. Improving molecular therapy in the kidney. Mol Diagn Ther 2020;24:375-96.
  25. Chung DC, Fogelgren B, Park KM, Heidenberg J, Zuo X, Huang L, et al. Adeno-associated virus-mediated gene transfer to renal tubule cells via a retrograde ureteral approach. Nephron Extra 2011;1:217-23. https://doi.org/10.1159/000333071
  26. Cherqui S. Hematopoietic stem cell gene therapy for cystinosis: from bench-to-bedside. Cells 2021;10:3273.
  27. Cystinosis Research Foundation (CRF) News. Stem Cell Trial Phase I/II Updates by Stephanie Cherqui, PhD [Internet]. CRF; 2022 [cited 2022 Dec 10]. Available from: https://www.cystinosisresearch.org/stem-cell-clinical-trial-update-by-stephanie-cherqui-phd/
  28. Berquez M, Gadsby JR, Festa BP, Butler R, Jackson SP, Berno V, et al. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease. Kidney Int 2020;98:883-96.  https://doi.org/10.1016/j.kint.2020.05.040